Literature DB >> 1252146

Modification of the actions of some neuroactive drugs by growth hormone.

L C Tang, G C Cotzias.   

Abstract

The flat serum growth hormone (GH) patterns of untreated parkinsonian patients develop diurnal rises during treatment with levodopa. This chronic exposure to excesses of GH might lead to the eventual emergence of the "on-off" phenomenon, which would indicate a need for animal experiments. Pretreatment of mice with GH increased (1) cerebral dopa and dopamine concentrations in levodopa-treated mice, (2) cerebral accumulation of injected tritiated apomorphine and tritiated thymidine, and (3) behavioral responses to levodopa, L-m-tyrosine, apomorphine hydrochloride, and oxotremorine.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1252146     DOI: 10.1001/archneur.1976.00500020059009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  5 in total

1.  Plasma DOPA levels and growth hormone response to levodopa in parkinsomism.

Authors:  A Galea-Debono; P Jenner; C D Marsden; J D Parkes; D Tarsy; J Walters
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-02       Impact factor: 10.154

2.  Endocrine aspects of bromocriptine therapy in Parkinsonism.

Authors:  K M Shaw; A J Lees; S Franks; P Daggett; B D Thompson; G M Stern
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

3.  Hypothalamic-pituitary-thyroid axis in acromegaly.

Authors:  E Carmina; F Rosato; S Pirronello; A Jannì
Journal:  J Endocrinol Invest       Date:  1983-08       Impact factor: 4.256

4.  Frequency-velocity mismatch: a fundamental abnormality in parkinsonian gait.

Authors:  Catherine Cho; Mikhail Kunin; Koji Kudo; Yasuhiro Osaki; C Warren Olanow; Bernard Cohen; Theodore Raphan
Journal:  J Neurophysiol       Date:  2009-12-30       Impact factor: 2.714

5.  L-3,4-dihydroxyphenylalanine-induced hypersensitivity simulating features of denervation.

Authors:  L C Tang; G C Cotzias
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.